NEW YORK (GenomeWeb News) – RainDance Technologies said this week that it has made the first commercial shipment of its RDT 1000 and Sequence Enrichment Solution. The Lexington, Mass.-based firm said that it had shipped the RDT 1000, consumables kits, and custom PCR prime libraries to the Ontario Institute for cancer Research, which will use the products in its discovery and validation of DNA sequence variants associated with cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Vivek Murthy is no longer the surgeon general of the US, the Associated Press reports.

People around the globe took to the streets to support science — some with signs.

Parents who learn of their increased genetic risk of disease also contend with telling their children about theirs, the New York Times writes.

In PLOS this week: loci linked to body mass index measurements, long non-coding RNA expression and urothelial carcinoma prognosis, and more.